Prosecution Insights
Last updated: October 27, 2026

Amanda L Aguirre, USPTO Patent Examiner

Listed by the USPTO as AGUIRRE, AMANDA L

Tech Center 1600 • Art Units: 1626

This examiner grants 77% of resolved cases

Analysis

AGUIRRE, AMANDA L is assigned to Tech Center 1600 and Art Unit 1626. The examiner has 559 resolved cases, an allowance rate of 77.3%, and a median of 868 days to allowance. Interviews show a 15.7% lift in allowance outcomes, making examiner contact a practical consideration alongside written claim and prior-art responses.

The leading company matters are AbbVie Inc., BASF SE, and The Regents of the University of Colorado. The listed firms are Adams & Reese LH, FOLEY & LARDNER LLP, and FOLEY HOAG, LLP (General). The profile provides counsel with a substantial historical base, an allowance-oriented outcome pattern, and a median timeline that should be incorporated into filing, response, and portfolio planning.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

77.3%
Allow Rate
+17.3% vs TC avg
572
Total Applications
+15.7%
Interview Lift
868
Avg Prosecution Days
Based on 559 resolved cases, 2023–2026

Rejection Statute Breakdown

1.6%
§101 Eligibility
25.1%
§102 Novelty
25.5%
§103 Obviousness
30.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18478718 AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDERECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS Non-Final OA Allergan, Inc.
17953221 SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER Final Rejection The Regents of the University of Colorado, a Body Corporate
18255891 METHODS AND SYSTEMS FOR PRODUCTION OF FURFURAL Non-Final OA Shell USA, INC.
17964603 INTEGRATED METHODS AND SYSTEMS FOR PRODUCING AMIDE AND NITRILE COMPOUNDS Non-Final OA Novomer LLC
18250493 USE OF SMALL MOLECULE FAK ACTIVATORS TO PROMOTE MUCOSAL HEALING Non-Final OA University of North Dakota

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Amanda L Aguirre's allowance rate?

77.3% of resolved applications examined by Amanda L Aguirre were allowed (559 resolved cases), compared with 54.9% across Art Unit 1626 over the last five years.

Does an interview help with examiner Amanda L Aguirre?

This examiner's interview lift is +15.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Amanda L Aguirre take to allow a patent?

Applications allowed by Amanda L Aguirre took 868 days on average from filing to allowance.

Which art unit does examiner Amanda L Aguirre work in?

Amanda L Aguirre examines applications in Art Unit 1626 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month